While studies of cultured cells have led to new insights into biological control, greater understanding of human pathophysiology requires the development of experimental systems that permit analysis of intercellular communications and tissue-tissue interactions in a more relevant organ context. Human organs-on-chips offer a potentially powerful new approach to confront this long-standing problem.
Biomedical research seeks to understand human physiology and how cellular behaviors become deregulated during disease development to discover more effective diagnostics, therapeutics, and means of disease prevention. To gain insight into the inner workings of life, biologists have reduced complex human organ systems into smaller and simpler subsystems such that most in vitro studies now involve analysis of only one type of cell or tissue cultured in isolation. While this approach has led to useful insights into cellular regulation, physiological control involves higher order intercellular communication, involving chemical, molecular, physical, and electrical information transfer between cells in different tissues, as well as functional coupling between different organs, and with each systems jump, new functions emerge. In addition, we now know that the normal microbiome that lives on and in our bodies is critical for health and disease. Thus, to gain a deeper understanding of human physiology and pathophysiology, we need to develop new in vitro methods to study cellular control in a more relevant, organ and multi-organ context.
Animal models are often used to address this challenge, but they often fail to faithfully mimic human response (Leist and Hartung, 2013) . Three dimensional (3D) ''organoid'' cultures have been developed that support formation of higher order tissue-like (Sato and Clevers, 2013) and even organ-like (Lancaster et al., 2013) structures; however, organoids lack many features that are critical for organ function, such as vascular perfusion, mechanical cues (e.g., breathing motions in lung), circulating immune cells, and the ability to co-culture normal microbiome for extended times. We currently do not have the technology to build a fully functional, living replica of a whole organ with the correct 3D spatial relationships and a one-to-one correspondence of part to whole down to the cellular and molecular levels. But even if we could accomplish this, it would not necessarily provide a way to selectively remove or add back individual cell and molecular components to analyze their contribution to organ-level behaviors, to visualize molecular scale activities at high resolution in real-time, or to carry out biochemical and genetic analysis of the interacting tissues individually, which are all are crucial for gaining insight into how intercellular signal transfer and tissue-tissue interactions contribute to physiological control. But there is another way to do this; we can ''reverse engineer'' living organs.
Reverse Engineering
Reverse engineering is the process of extracting basic design information, usually from a man-made system or device, and using this knowledge to reproduce a new equivalent or improved technology. This process usually involves disassembling the device and analyzing its components and workings in detail, and this is precisely what biologists have been doing with living systems for the past century.
But rather than trying to identify key component parts or mechanisms (as is the main focus of biology), reverse engineering seeks to identify the minimal set of design principles that are necessary to reconstitute relevant functions of the whole.
Virtually all organs contain an interface between a parenchymal tissue (e.g., epithelium, connective tissue, nerve tissue) and a vascular tissue (blood vessel) that perfuses the organ with crucial oxygen and nutrients, delivers immune cells, and transfers chemical, molecular, and hormonal signals from one organ to another. All organs also experience characteristic mechanical forces (e.g., cyclic strain, compression, shear) as well as neuroelectrical cues that are crucial for normal organ physiology. Thus, if one were to reverse engineer an organ, it would be critical to reconstitute characteristic tissue-tissue interfaces, ensure vascular perfusion, and provide an organ-relevant physical microenvironment. These are the precise minimal design principles that inspired the development of ''organs-on-chips,'' which now permit in vitro analysis of how cells collaborate within human tissues and organs to regulate normal physiology, as well as promote disease development.
Organs-on-Chips
Organs-on-chips are microfluidic cell culture devices created with computer microchip manufacturing techniques that contain hollow microchannels lined by living cells and tissues cultured within an organ-relevant physical context, which are continuously perfused with life-sustaining culture medium (Bhatia and Ingber, 2014) . This field has now advanced to the point where it is possible to engineer microfluidic organs-on-chips that contain complex, organ-specific, tissuetissue interfaces (e.g., alveolar-capillary interface) by culturing different cell types on the opposite sides of a common extracellular matrix (ECM)-coated, porous membrane that separates two, independently perfused, parallel microchannels within a single microfluidic device (Huh et al., 2010; Achyuta et al., 2013; Kim et al., 2016; Benam et al., 2016) . Similar tissue-tissue interfaces have been created using a viscous fingering technique to form a cylindrical ECM gel within a microfluidic channel containing a central lumen that can be lined by one type of tissue (e.g., epithelium) while culturing another cell type (e.g., fibroblasts) in the surrounding gel (Bischel et al., 2015; Herland et al., 2016) . Relevant mechanical forces can be applied to recreate physiological movements (Huh et al., 2010; Kim et al., 2016) and fluid shear stresses (Bhatia and Ingber, 2014; Achyuta et al., 2013; Kim et al., 2016; Benam et al., 2016; Bischel et al., 2015; Herland et al., 2016) ; air-liquid interfaces can be recreated by introducing air into the parenchymal tissue channel (Huh et al., 2010; Benam et al., 2016) ; and electrical signals can even be applied by integrating electrodes into the devices (Douville et al., 2010) . Additional tissue types also can be integrated into the system, including circulating immune cells (Huh et al., 2010; Kim et al., 2016; Benam et al., 2016) , connective tissue cells (Bischel et al., 2015) , neuronal cells (Achyuta et al., 2013) , and even living microbiome (Kim et al., 2016) to study more complex tissue-tissue interactions and more faithfully mimic complex organ-level responses. The chips may be populated with primary human cells, cell lines, stem cells or inducible pluripotent stem cells from healthy or diseased human patients. Finally, the vascular channels of different organ chips can be linked fluidically to study higher order, multi-organ physiological coupling (Maschmeyer et al., 2015; Esch et al., 2014) . And all of this can be done while carrying out high-resolution, real-time imaging, and in vitro analysis of biochemical, genetic, and metabolic responses.
Intercellular communication in a human organ context in vitro
Microfluidic devices have been used for many years to probe cell-cell interactions; to explore the effects of chemical or cytokine gradients on cell behavior; and to study the effects of drugs, toxins, and mechanical forces on cultured cells and tissues in vitro (Bhatia and Ingber, 2014) . More recently, however, organs-on-chips that incorporate more complex tissue-tissue interfaces have begun to be used to study how cells within different tissues exchange molecular signals, collaborate, and respond to physical cues to regulate complex organ-level physiology and contribute to disease development. Blood-Brain Barrier For example, a blood-brain-barrier (BBB)-on-a-chip has been developed and used to analyze intercellular signaling that mediates neuroinflammation. Rat brain microvascular endothelial cells are cultured in a microchannel on one side of a porous membrane, and a mixture of brain neurons and supporting astrocytes and microglial cells are grown on the other to recreate the neurovascular unit (Achyuta et al., 2013) . Addition of the inflammatory cytokine, TNF-a, to the vascular channel results in increased expression of the vascular adhesion molecule ICAM-1 on the surface of the neighboring endothelium as well as concomitant activation of the adjacent microglia and astrocytes (as indicated by upregulation of GFAP), much as is observed in neuroinfectious diseases in vivo. Use of this microengineered BBB model reveals that this response is mediated by the intact endothelium and is not merely due to a leaky vasculature. The neuronal cells also produce detectable inhibitory and exciting potentials, and thus, contributions of electrical signals to normal BBB function could be studied using this model in the future.
More recently, neuroinflammation has been analyzed using a 3D microfluidic model of an all human BBB composed of a hollow cylindrical ECM gel filled with astrocytes and a central lumen lined by brain microvascular endothelium and circumferential pericytes (Herland et al., 2016) , which closely mimicks the natural BBB. Stimulation of this endothelium with TNF-a results in unique expression profiles of the inflammatory cytokines G-CSF and IL-6 that mediate neuroprotection and neuroactivation in vivo, depending on whether pericytes or astrocytes are present in the surrounding ECM, and these profiles are different than those expressed by cells grown in static Transwell co-cultures. Lung Studies using a human lung-on-a-chip that reconstitutes the alveolar-capillary interface demonstrates that the addition of either TNF-a, simulants of airborne pollutants (12 nm silica nanoparticles), or living bacteria to the epithelial space not only induces expression of ICAM-1 in the underlying endothelium, it also results in enhanced recruitment of circulating human neutrophils when they are perfused through the vascular channel (Huh et al., 2010) . Due to their high visual clarity, these devices enable high-resolution microscopic analysis of the multicellular interactions that mediate human lung inflammation. In addition, by applying cyclic suction to microchambers that run parallel to the culture channels, it is possible to mimic normal breathing motions in this lung chip by rhythmically stretching and relaxing the porous membrane and adherent tissue layers. Interestingly, neither epithelial injury nor activation of the endothelium and the downstream inflammatory response are observed in the absence of physiological breathing motions. This ability to analyze physiological responses at the organ level also resulted in the discovery that transcytosis of the nanoparticles across both the epithelial and endothelial tissue layers, and their resulting absorption into the vascular channel, are similarly sensitive to cyclic mechanical cues, and again this response is not observed in static chips or Transwell co-cultures. Importantly, this previously unknown mechanosensitive signaling response has been confirmed to be physiologically relevant in that it also is observed in whole lung when similar studies are carried out in an ex vivo mouse ventilation-perfusion model.
Thus, use of this lung alveolus-on-achip has uncovered previously unknown regulatory mechanisms that involve interplay among three human tissue types (epithelial, endothelial, and immune) as well as microbial pathogens, and their sensitivity to physiological breathing motions. It is also important to note that the synthetic nature of the organ-on-a-chip model can sometimes lead to unexpected findings relating to physiological control. One example is the discovery that immune cells, which have been assumed to be key contributors to pulmonary edema, are not required for pulmonary vascular leakage induced by the cancer drug, interleukin-2 (IL-2), which induces a fluid shift from the vascular channel to the air space in the lung alveolus-on-a-chip when only lung epithelium and endothelium are present . Analysis of this response also revealed that induction of pulmonary edema by IL-2 requires physiological breathing motions, and analysis of this signaling pathway resulted in the identification of the mechanosensitive ion channel, TRPV4, as a potential new therapeutic target.
Another form of tissue-tissue crosstalk was observed in a human small airway-ona-chip model (Benam et al., 2016) . When primary human bronchiolar epithelium and pulmonary microvascular endothelium are cultured on opposite sides of a common porous membrane and exposed on-chip to the viral mimic poly(I:C), a proinflammatory response is induced that is highly similar to that observed in humans with acute severe asthma exacerbations, including large increases in the basal secretion of RANTES, IL-6, and IP-10. Interestingly, levels of these inflammatory cytokines are 3-to 6-fold higher when underlying endothelium is present compared to when the epithelium, which is the primary source of these cytokines, is stimulated in isolation. Moreover, this collaborative organ-level effect appears synergistic, and it is specific in that removal of the endothelium has no effect on secretion of other inflammatory mediators (e.g., GRO-a, IL-8). At the same time, the poly(I:C) stimulated upregulation of E-selectin and VCAM-1 expression in the underlying endothelium stimulates adhesion and rolling of human neutrophils circulating through the vascular channel under flow. Again, because neutrophil adhesion and rolling require fluid shear stress, this response cannot be easily studied using static Transwell co-cultures. Thus, use of this small airway-on-a-chip reveals intrinsic crosstalk between human lung airway epithelium and endothelium during inflammation and confirms past animal studies suggesting that the pulmonary endothelium acts as a central regulator of the cytokine storm during virus-induced inflammation.
The small airway-on-a-chip also provides a new way to study lung diseases (Benam et al., 2016) . Exposure of the human bronchiolar epithelium to the cytokine IL-13 produces goblet cell hyperplasia, cytokine hypersecretion, and decreased ciliary function similar to that seen in asthmatic patients. When the chips are fabricated using airway cells from patients with chronic obstructive pulmonary disease (COPD), the epithelium continues to express the COPD phenotype (e.g., downregulation of TLR receptors) and exhibit enhanced inflammatory exacerbations by simulants of bacterial and viral infection in vitro compared to normal lung chips; in fact, this work led to the identification of a new biomarker of virus-induced exacerbation in COPD (Benam et al., 2016) . Intestine Experiments with a human gut-on-a-chip that reconstitutes the villus structure and function of the small intestine (Figure 1 ) have enabled study of even more complex multicellular interactions involving human intestinal epithelial cells, endothelial cells, and immune cells, in the presence of both living commensal microbes and pathogenic enteroinvasive bacteria, while also being exposed to physiological peristalsis-like motions and fluid flow (Kim et al., 2016) . While most past studies on gut microbiota have relied upon gene sequencing to identify the relevant microbial strains that are present in normal or diseased intestine, the mechanically This schematic illustration of a cross-section of the human small intestine-ona-chip with a higher magnification inset shows two parallel channels of a microfluidic device composed of a flexible optically clear polymer separated by a porous ECM-coated membrane composed of the same material, which has hollow chambers on either side through which cyclic suction is applied to repeatedly stretch and release of the central membrane to mimic peristalsislike motions. A human villus intestinal epithelium is cultured on the top surface of the membrane and exposed to trickling fluid flow (arrow) in the upper ''luminal'' channel, while human vascular endothelium (red) is grown on the opposite surface of the same membrane in the lower ''vascular'' channel where it is exposed to continuous flow (arrow) of culture medium. To add greater organ-level complexity, commensal microbes of the normal gut microbiome can be co-cultured with the epithelium where they stably engraft in the regions between neighboring villi. Circulating human immune cells (white) also can be circulated through the vascular channel, and the epithelium can be challenged with enteroinvasive bacterial pathogens to examine responses to infection. In this manner, this organ-on-a-chip can permit analysis of multiple potential contributors to intestinal pathophysiology (epithelium, endothelium, immune cells, microbiome, pathogens, and physical forces) by enabling these parameters to varied one-at-a-time or in combination while carrying out highresolution real-time microscopic imaging as well as biochemical and genetic analysis of tissues and components in the effluents of both fluidic channels.
active gut-on-a-chip has made it possible to co-culture human intestinal epithelial cells with a living microbiome for weeks in vitro, which again is not possible using static Transwells or 3D organoid cultures due to bacterial overgrowth and contamination (Kim et al., 2016; Kim et al., 2012) . Interestingly, when gene microarray analysis is carried out in the mechanically active microfluidic chip and in static Transwell dishes, with cells cultured in the presence or absence of eight normal commensal gut microbes, the presence of physiological mechanical forces changes thousands of different genes, and the further addition of normal microbiome elicits signals that result in development of a distinct epithelial phenotype that closely resembles that of the human ileum, which is the part of the small intestine where microbes are most frequently observed in vivo (Kim et al., 2016) .
Use of this human gut-on-a-chip, which permits one to study multiple potential contributing factors alone or in combination, reveals how intestinal cells, immune cells, normal microbiome and pathogenic bacteria contribute to disease development, associated inflammation and host tolerance to infection. For instance, the intestinal epithelium is found to be tolerant to lipopolysaccharide endotoxin (LPS) or primary human immune cells (peripheral blood mononuclear cells) when added individually; however, both normal intestinal villus morphology and barrier function are lost when an enteroinvasive pathogenic strain of E. coli is cultured in the epithelial channel. In contrast, when human immune cells are flowed through the vascular channel at the same time that the epithelium is exposed to LPS, a significant intestinal injury response is observed that is reminiscent of that seen in patients with inflammatory bowel disease. Because it is possible to analyze the effluent of the epithelial and vascular microchannels independently, this approach also led to the identification of a specific combination of four cytokines that are secreted by the epithelium in a polarized fashion into the vascular channel in response to stimulation with LPS, but only when immune cells were present. This cytokine combination is necessary and sufficient to induce the intestinal damage produced by the combination of LPS and immune cells in this model. In addition, because of the synthetic nature of the organ-on-a-chip approach, it is possible to cease peristalsis-like motions while maintaining fluid flow constant in this study. This experiment revealed that cyclic mechanical deformation of the intestine serves to restrain microbial proliferation as cessation of these motions leads to overgrowth of otherwise nonpathogenic bacteria (Kim et al., 2016) , much as is observed in patients with decreased intestinal motility (e.g., in ileus). Thus, using the organ-on-a-chip approach, it is possible to study interplay between multiple different types of cells and tissues (epithelium, endothelium, immune cells, commensal microbiome, and pathogenic bacteria), molecular components they produce (e.g., cytokines, LPS), and physical cues from their environment in a human organ-relevant microenvironment (Figure 1 ) and, as a result, to gain new insights into human pathophysiology. Cancer The organ-on-a-chip approach also has been used to study human cancer progression in vitro. For example, normal mammary epithelial cells have been cultured on the inner surface of a cylindrical channel formed within an ECM gel inside a microfluidic device using the viscous finger patterning method. The lumen is then filled with breast ductal carcinoma in situ (DCIS) cells and mammary fibroblasts are included in the ECM gel to recreate a DCIS-like lesion. Inclusion of fibroblasts promotes cancer progression, as indicated by increased invasion of the DCIS cells in this model. Linking Multiple Organ Chips Multiple researchers have also linked different organ chips fluidically to study drug metabolism and carry out pharmacokinetic/pharmacodynamic modeling (Bhatia and Ingber, 2014) . However, more recently, this human body-on-chips approach also has been applied to analyze physiological coupling between different organs in vitro. In one recent study, human intestine, liver, and skin chips were linked fluidically to each other and to a kidney chip separated from the other chips by a permeable membrane, which separated media flow through the organs from fluids excreted by the kidney chip (Maschmeyer et al., 2015) . This linked four-organ-chip system reproducibly establishes and maintains physiological homeostasis, as indicated by the ability of the intestinal and kidney barriers to maintain a continuously stable glucose gradient balance between the intestinal lumen, the culture medium circuit, and the excretory circuit of the system, for at least 4 weeks in culture. Using a similar approach, another group has shown that ingested nanoparticles absorbed through a gastrointestinal chip have the potential to cause injury in a linked liver chip (Esch et al., 2014) . Although fluids are transferred directly between the parenchymal tissue spaces of these organ chips and not via a physiologically relevant endothelium-lined vascular channel, this work demonstrates the potential to study signal transfer between different organs and to analyze physiological human organ-organ coupling in vitro.
Conclusion
In this article, I summarized a few recent examples of studies that provide a glimpse of what is now possible using human organs-on-chips, and the unique advantages this approach can provide beyond those offered by existing culture systems used to study intercellular communication in vitro. Because these organ-on-a-chip devices offer a synthetic biology approach to vary potential control parameters one-at-a-time or in combination, while also providing a window on molecular scale activities of living cells in a functional tissue and organ context, they essentially enable a novel form of mechanistic human experimentation in vitro. As these chips can be created using induced pluripotent stem cells, these microphysiological systems potentially could be created using cells isolated from unique genetic subpopulations or even specific individuals, thereby permitting analysis of complex organ-level physiology and disease mechanisms in a more personalized way in the future. The field is clearly still in its infancy, and there is much yet to be done in terms of optimizing system robustness and incorporating additional complexity into the models. But the possibilities for deciphering how cells communicate with each other inside human tissues and organs, and even how information is transferred from one organ to another, are enormous.
